ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
B06AC01 - C1-Inhibitor, Plasma DerivedATC-DDD Version 2016. Source: WHO
B - Blood and Blood Forming Organs
 
B06 - Other Hematological Agents
 

No DDDs are established in this group.

B06A - Other Hematological Agents

This group includes preparations for local and systemic use, and also some preparations used for dissolving clots in catheters, hemodialysis clots etc.
See also:
V07A - All other non-therapeutic products
B01AB - Heparin group

B06AC - Drugs Used in Hereditary Angioedema
 

The DDD for lanadelumab is based on the starting dose.

B06AC01 - C1-Inhibitor, Plasma Derived
DoseRoute of administrationNote
 P 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home